Your browser doesn't support javascript.
loading
Residual meta-iodobenzyl guanidine (MIBG) positivity following therapy for metastatic neuroblastoma: Patient characteristics, imaging, and outcome.
Usmani, Nida; Deyell, Rebecca J; Portwine, Carol; Rafael, Margarida Simao; Moorehead, Paul C; Shammas, Amer; Vali, Reza; Farfan, Mateo; Vanniyasingam, Thuvaraha; Morgenstern, Daniel A; Irwin, Meredith S.
Afiliación
  • Usmani N; Department of Pediatrics, Division of Hematology and Oncology, McMaster Children's Hospital, Hamilton, Ontario, Canada.
  • Deyell RJ; Department of Pediatrics, Division of Hematology/Oncology/BMT, BC Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
  • Portwine C; Department of Pediatrics, Division of Hematology and Oncology, McMaster Children's Hospital, Hamilton, Ontario, Canada.
  • Rafael MS; Department of Pediatrics, Division of Hematology and Oncology, Janeway Children's Health and Rehabilitation Centre, and Memorial University, St. John's, Newfoundland and Labrador, Canada.
  • Moorehead PC; Department of Pediatrics, Division of Hematology and Oncology, Janeway Children's Health and Rehabilitation Centre, and Memorial University, St. John's, Newfoundland and Labrador, Canada.
  • Shammas A; Department of Diagnostic Imaging, The Hospital for Sick Children and University of Toronto, Toronto, Ontario, Canada.
  • Vali R; Department of Diagnostic Imaging, The Hospital for Sick Children and University of Toronto, Toronto, Ontario, Canada.
  • Farfan M; Department of Pediatrics, Division of Hematology/Oncology/BMT, BC Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
  • Vanniyasingam T; Biostatistics Unit, St. Joseph's Healthcare, Hamilton, Ontario, Canada.
  • Morgenstern DA; Department of Pediatrics, Division of Hematology & Oncology, The Hospital for Sick Children and University of Toronto, Toronto, Ontario, Canada.
  • Irwin MS; Department of Pediatrics, Division of Hematology & Oncology, The Hospital for Sick Children and University of Toronto, Toronto, Ontario, Canada.
Pediatr Blood Cancer ; 68(12): e29289, 2021 12.
Article en En | MEDLINE | ID: mdl-34411405

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Primarias Secundarias / Neuroblastoma Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Pediatr Blood Cancer Asunto de la revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Año: 2021 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Primarias Secundarias / Neuroblastoma Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Pediatr Blood Cancer Asunto de la revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Año: 2021 Tipo del documento: Article País de afiliación: Canadá